EP3993905A1 - Mikrofluidische vorrichtung zum prozessieren und aliquotieren einer probenflüssigkeit, verfahren und steuergerät zum betreiben einer mikrofluidischen vorrichtung und mikrofluidisches system zum durchführen einer analyse einer probenflüssigkeit - Google Patents
Mikrofluidische vorrichtung zum prozessieren und aliquotieren einer probenflüssigkeit, verfahren und steuergerät zum betreiben einer mikrofluidischen vorrichtung und mikrofluidisches system zum durchführen einer analyse einer probenflüssigkeitInfo
- Publication number
- EP3993905A1 EP3993905A1 EP20736618.8A EP20736618A EP3993905A1 EP 3993905 A1 EP3993905 A1 EP 3993905A1 EP 20736618 A EP20736618 A EP 20736618A EP 3993905 A1 EP3993905 A1 EP 3993905A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- sample liquid
- liquid
- chamber
- cavities
- microfluidic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 295
- 238000011166 aliquoting Methods 0.000 title claims abstract description 79
- 238000012545 processing Methods 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims description 42
- 238000004458 analytical method Methods 0.000 title description 9
- 238000007789 sealing Methods 0.000 claims abstract description 74
- 239000012530 fluid Substances 0.000 claims abstract description 20
- 238000006243 chemical reaction Methods 0.000 claims abstract description 6
- 238000009826 distribution Methods 0.000 claims description 31
- 238000005192 partition Methods 0.000 claims description 13
- 238000000638 solvent extraction Methods 0.000 claims description 13
- 238000001514 detection method Methods 0.000 claims description 11
- 238000007872 degassing Methods 0.000 claims description 9
- 230000002572 peristaltic effect Effects 0.000 claims description 8
- 230000007704 transition Effects 0.000 claims description 8
- 238000009423 ventilation Methods 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 5
- 238000005496 tempering Methods 0.000 claims description 3
- 230000003247 decreasing effect Effects 0.000 claims 1
- 238000005086 pumping Methods 0.000 abstract description 15
- 239000000523 sample Substances 0.000 description 150
- 239000012071 phase Substances 0.000 description 44
- 230000032258 transport Effects 0.000 description 30
- 238000011049 filling Methods 0.000 description 13
- 238000012546 transfer Methods 0.000 description 11
- 230000008901 benefit Effects 0.000 description 10
- 230000006870 function Effects 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 230000006641 stabilisation Effects 0.000 description 6
- 238000011105 stabilization Methods 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000005501 phase interface Effects 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 238000001327 Förster resonance energy transfer Methods 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000005499 meniscus Effects 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 239000013610 patient sample Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920005597 polymer membrane Polymers 0.000 description 2
- 229920000307 polymer substrate Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- QDOIZVITZUBGOQ-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,4-nonafluoro-n,n-bis(1,1,2,2,3,3,4,4,4-nonafluorobutyl)butan-1-amine;1,1,2,2,3,3,4,4,4-nonafluoro-n-(1,1,2,2,3,3,4,4,4-nonafluorobutyl)-n-(trifluoromethyl)butan-1-amine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F.FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F QDOIZVITZUBGOQ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000003891 environmental analysis Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- RVZRBWKZFJCCIB-UHFFFAOYSA-N perfluorotributylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RVZRBWKZFJCCIB-UHFFFAOYSA-N 0.000 description 1
- AQZYBQIAUSKCCS-UHFFFAOYSA-N perfluorotripentylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F AQZYBQIAUSKCCS-UHFFFAOYSA-N 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229920006132 styrene block copolymer Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/02—Adapting objects or devices to another
- B01L2200/026—Fluid interfacing between devices or objects, e.g. connectors, inlet details
- B01L2200/027—Fluid interfacing between devices or objects, e.g. connectors, inlet details for microfluidic devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0605—Metering of fluids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0673—Handling of plugs of fluid surrounded by immiscible fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0684—Venting, avoiding backpressure, avoid gas bubbles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/14—Process control and prevention of errors
- B01L2200/142—Preventing evaporation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/12—Specific details about materials
- B01L2300/123—Flexible; Elastomeric
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/18—Means for temperature control
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0457—Moving fluids with specific forces or mechanical means specific forces passive flow or gravitation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/06—Valves, specific forms thereof
- B01L2400/0622—Valves, specific forms thereof distribution valves, valves having multiple inlets and/or outlets, e.g. metering valves, multi-way valves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
Definitions
- Microfluidic device for processing and aliquoting a
- the invention is based on a device or a method according to the preamble of the independent claims.
- Microfluidic analysis systems so-called lab-on-chips or LoCs for short, allow in particular an automated, reliable, fast, compact and inexpensive processing of patient samples for medical diagnostics.
- complex molecular diagnostic test sequences can be carried out on a lab-on-chip cartridge.
- An important operation is the aliquoting of a liquid volume, which forms the basis for highly parallelized sample processing and for molecular diagnostic sample analyzes with a high degree of multiplexing.
- polymerase chain reactions that are independent of one another can be carried out in individual aliquots of the liquid, which allow amplification of specific deoxyribonucleic acid base sequences and thus a highly sensitive, molecular diagnostic detection.
- Techniques that are already established for aliquoting a sample liquid in a microfluidic device can, for example, in addition to the sample input into the device, have further steps to be carried out manually, which are not easily accessible to automation and / or may in particular not offer a microfluidic environment or connection to a microfluidic environment, which would allow automated preprocessing of the sample prior to aliquoting, for example a
- Sample preparation for the extraction of deoxyribonucleic acids from the sample, within the microfluidic device would allow.
- Existing techniques for aliquoting a sample liquid within a microfluidic environment can be based, for example, on evacuating the cavities or compartments, or on centrifuging the device, in which the centrifugal force along an inlet opening of the
- the device and the method enable a high transfer efficiency of the sample liquid from the microfluidic network into the cavities of the aliquoting structure in order to be able to achieve processing of the sample liquid with as little loss as possible. It would also be desirable to have a microfluidic device and a method which neither evacuates the compartments nor such centrifugation for the automated aliquoting of a
- a microfluidic substrate According to embodiments, a microfluidic
- Apparatus and a method are provided which allow an automated aliquoting of a liquid, in particular a sample liquid, in an aliquoting structure, in particular in a cavity array structure.
- a device with an aliquoting structure which is connected to a microfluidic network, and a method can be provided in which, in addition to a
- Processing of the liquid to be aliquoted can take place in the microfluidic network before the aliquoting.
- Processing of the liquid to be aliquoted can take place in the microfluidic network before the aliquoting.
- Cavity array structure can be provided to a microfluidic network, which has a capillary and additionally or alternatively stabilization of the liquids used by differences in density
- Phase interfaces can enable a transfer of liquids into the chamber with the aliquoting structure in order to achieve in particular a reliable filling and sealing of all cavities as well as a high transfer efficiency.
- the aliquoting structure in addition to the processing of a small volume of a sample liquid as a first phase in a microfluidic network and a transport of the sample liquid to the aliquoting structure, the aliquoting structure can initially be carried out with the
- Allow reagents in the cavities or compartments of the aliquoting structure in particular of dried-on substances which dissolve in the sample liquid without the reagents being able to come into contact beforehand with a liquid phase other than the sample liquid.
- the filled cavity can be sealed with the sealing liquid as the second phase.
- the capillary forces that occur in the cavities or compartments of the aliquoting structure can be used to suitably align the microfluidic
- the sample liquid can be aliquoted even if only a small amount of sample liquid is present. Conversely, a small amount of sample liquid can be sufficient to fill the cavities or compartments of the aliquoting structure with the sample liquid.
- a high transfer efficiency can therefore be achieved.
- a high transfer efficiency can in turn enable a high sensitivity of, for example, molecular diagnostic analyzes of the sample liquid.
- a microfluidic device for processing and aliquoting a sample liquid having the following features: a partition chamber for receiving an input volume of the sample liquid
- Sample liquid the dividing chamber having a plurality of cavities for receiving partial volumes of the sample liquid which can be used for detection reactions; a microfluidic network for fluid-mechanical development of the sample liquid
- the microfluidic network has at least one inlet channel and one discharge channel connected fluid-mechanically to the distribution chamber; and at least one pumping device for conveying fluids within the device, the at least one pumping device and the microfluidic network being designed to convey the sample liquid as a first phase through the microfluidic network into the partitioning chamber in order to
- the microfluidic device can be at least part of a microfluidic lab-on-chip or chip laboratory for medical diagnostics, microbiological diagnostics or environmental analysis.
- a liquid to be analyzed typically a liquid or liquefied one, can be used as the sample liquid
- Patient sample e.g. B. blood, urine, stool, sputum, liquor, lavage, a rinsed smear or a liquefied tissue sample, or a sample of one
- the input volume of the sample liquid can correspond to a volume of the sample liquid introduced into the distribution chamber.
- the partial volumes of the sample liquid can be aggregated or separated in the cavities. Aliquoting can be understood to mean subdividing large volumes of liquid into small ones and enclosing them in individual reaction chambers or cavities.
- Sample liquid can be of the same size or of different sizes
- Partial volume sections, partial volumes or cavities are divided.
- the plurality of cavities can represent an aliquoting structure.
- the two phases may not be miscible with one another, or only slightly.
- Influencing a fluid flow in the area of the channel branch can be provided.
- Such an embodiment offers the advantage that an inexpensive and reliable fluid control can be achieved, in particular with
- the microfluidic device can have the sample liquid and the sealing liquid.
- the device can be designed to store the sample liquid and the sealing liquid outside the partitioning chamber.
- the device can have at least one chamber for pre-storing or holding the sample liquid and the
- the device can also be a
- the device can have temperature control device for controlling the temperature of the partial volumes of the sample liquid arranged in the cavities. Additionally or alternatively, the device can have a detection device for optically detecting at least one property of the partial volumes arranged in the cavities
- the feed duct can also be branched into at least two sub-ducts opening into the dividing chamber.
- at least one dimension of a fluid channel cross-section can be reduced in an area where the sub-channels meet in the partitioning chamber.
- microfluidic network can be achieved in the compartments of the aliquoting structure, since then a small amount of sample liquid is sufficient to wet all areas of the aliquoting structure.
- microfluidic flow can be achieved before being introduced into the distribution chamber. This can support that the interfaces of the
- Multi-phase system can be introduced spatially as homogeneously as possible over the entire width of the aliquoting structure in the partitioning chamber.
- the cavities can be formed in a chip that is in the
- Distribution chamber is arranged.
- at least one dimension of a fluid-carrying area of the distribution chamber can be reduced in a transition area to the chip in the distribution chamber.
- a capillary-assisted alignment of a liquid meniscus along the entire width of the chip can be promoted before the liquid wets an upper side of the chip with the cavities.
- the width of the chip also supports the formation of a homogeneous flow profile in the distribution chamber.
- the device can have at least one elastic membrane, which can be deflected into at least one pump chamber in order to implement the function of the at least one pump device, and additionally or alternatively can be deflected into at least one valve chamber in order to implement the function of the at least one valve.
- at least one elastic membrane which can be deflected into at least one pump chamber in order to implement the function of the at least one pump device, and additionally or alternatively can be deflected into at least one valve chamber in order to implement the function of the at least one valve.
- the device can have a plurality of
- the pump devices can be designed to carry fluid in the microfluidic network
- the pump devices can be designed to convey different fluid volumes per pump cycle. Additionally or alternatively, the pump devices can function as a peristaltic pump unit. Such an embodiment offers the advantage that a defined flow rate can be set in an exact manner.
- Compartments are made in the aliquoting structure. As a result, the occurrence of undesired dynamic effects, for example caused by inertial forces, such as, for example, the inclusion of air bubbles in the cavities, can be avoided.
- Sealing liquid can seal the as quickly as possible Compartments take place, for example, to keep an undesired exchange of substances between adjacent cavities as low as possible. Furthermore, by using a peristaltic pump device with low
- Multi-phase system can be achieved through the microfluidic network.
- the stability of the multiphase system when passing through the pump device can in particular be established by a small cross-sectional area of the peristaltic pump chambers and the dominant capillary forces.
- a precise definition of the absolutely transported volume of liquid also results from the small pumping volume of the peristaltic pumping device.
- the transport can be made here in integer multiples of the product
- the device can also have a further chamber, which is connected fluid-mechanically parallel to the at least one inlet channel and is fluid-mechanically connected to a ventilation channel, and a further temperature control device for temperature control of fluid arranged in the further chamber.
- a further chamber which is connected fluid-mechanically parallel to the at least one inlet channel and is fluid-mechanically connected to a ventilation channel, and a further temperature control device for temperature control of fluid arranged in the further chamber.
- a method for operating an embodiment of the aforementioned microfluidic device is also presented, the method having the following steps:
- This method can, for example, be in software or hardware or in a mixed form of software and hardware, for example in a control device be implemented. Between the step of introducing and the step of effecting, the method can have a step of inputting the device into a microfluidic system or a processing unit for controlling a microfluidic flow within the device.
- the step of bringing about a promotion can be a substep of producing a multi-phase system from the
- the step of effecting a promotion can be a substep of transporting the multiphase system by means of the at least one
- the at least one valve can be controlled in such a way that a transport liquid optionally present in the multiphase system via the
- the step of bringing about a delivery can have a partial step of introducing the sample liquid followed by the sealing liquid via the supply channel into the distribution chamber.
- the at least one valve can be reversed.
- Sealing liquid can be realized by the same liquid.
- a transport of the sample liquid to the aliquoting structure in the microfluidic system without dead volume can initially be made possible.
- the sample liquid and then another Liquid, in particular the sealing liquid, which serves to seal the cavities filled with the sample liquid can be introduced into the partitioning chamber. In particular, it can be prevented that
- Transport liquid penetrates undesirably into the cavities of the aliquoting structure and fills them before the sample liquid reaches the cavities.
- microfluidic network and the aliquoting structure are processed. Furthermore, by avoiding dead volumes, an increased efficiency of the sample liquid transfer from the microfluidic network into the cavities of the aliquoting structure can be achieved. In addition, by using a transport liquid and embedding the
- Sample liquid as the first phase for example a master mix for a polymerase chain reaction, which contains purified sample material
- the sealing liquid as the second phase for example a fluorinated hydrocarbon
- the transport liquid as the third phase for example silicone oil or a mineral oil
- Sealing liquid can be reduced, since this can also be transported to the aliquoting structure or the cavities in the distribution chamber without dead volume.
- the method can also have a step of temperature control of the partial volumes of the sample liquid arranged in the cavities.
- the temperature control step can be repeated cyclically.
- the method can include a step of optically detecting at least one property of the partial volumes arranged in the cavities
- Sample liquid can be detected via optical fluorescence.
- Such Embodiment has the advantage that the analysis of the aliquoted
- Sample liquid can be implemented in an exact and simple manner.
- the method can have a step of thermal degassing of the sample liquid and additionally or alternatively the sealing liquid in a further chamber, which is connected fluid-mechanically in parallel to the at least one inlet channel and is fluid-mechanically connected to a ventilation channel.
- the method can also include a step of displacing the
- Sealing liquid which seals the partial volumes of the sample liquid arranged in the cavities, by means of sealing liquid which has been thermally degassed in the step of thermal degassing.
- Embodiment offers the advantage that the analysis of the sample liquid can be carried out particularly reliably and precisely, since the formation of gas bubbles can be avoided during thermal processing of the sealed partial volumes of the sample liquid.
- Liquids acting gravitational force can be used to achieve a spatially homogeneous propagation of the two-phase interface through the partition chamber due to the existing density difference of the liquids. This is particularly advantageous when at least one spatial dimension of the partitioning chamber exceeds the size scale up to which capillary forces are dominant.
- the approach presented here also creates a control device which is designed to perform the steps of a variant of a method presented here in
- This embodiment variant of the invention in the form of a control device also enables the object on which the invention is based to be achieved quickly and efficiently.
- control device can have at least one processing unit for processing signals or data, at least one storage unit for storing signals or data, at least one interface to a sensor or an actuator for reading in sensor signals from the sensor or for outputting control signals to the actuator and / or at least one
- the computing unit can be, for example, a signal processor, a microcontroller or the like, wherein the storage unit can be a flash memory, an EEPROM or a magnetic storage unit.
- the communication interface can be designed to read in or output data wirelessly and / or wired, with a communication interface that can input or output wired data, for example, feed this data electrically or optically from a corresponding data transmission line or output it into a corresponding data transmission line.
- a control device can be understood to mean an electrical device that processes sensor signals and outputs control and / or data signals as a function thereof.
- the control device can have an interface that can be designed in terms of hardware and / or software. With a hardware design, the interfaces can be part of a so-called system ASIC, for example, which has a wide variety of functions
- Control unit includes.
- the interfaces are separate, integrated circuits or at least partially consist of discrete components.
- the interfaces can be software modules that are present, for example, on a microcontroller alongside other software modules.
- microfluidic system for performing an analysis of a sample liquid
- the system having the following features: an embodiment of the aforementioned microfluidic device; and an embodiment of the aforementioned control device, wherein the microfluidic device is operably connected to the control device.
- the control device can be part of a processing unit for controlling the microfluidic flow within the device.
- the microfluidic device can be mechanically, fluidically, pneumatically, optically and / or magnetically connected to the control device.
- the microfluidic system can be a so-called lab-on-chip system.
- the device can for example be designed as a cartridge for the system.
- control device controls a microfluidic flow within the device.
- the control takes place via pneumatic, hydraulic, mechanical, electrical and additionally or alternatively magnetic actuators such as pumps, valves, elastic membranes, magnets and the like via suitable interfaces.
- a computer program product or computer program with program code which can be stored on a machine-readable carrier or storage medium such as a semiconductor memory, a hard disk or an optical memory, and for carrying out, converting and / or controlling the steps of the method according to one of the above is also advantageous
- Embodiments described is used, in particular when the program product or program is executed on a computer or a device.
- a microfluidic device and a method can be provided which allow automated aliquoting of a sample liquid in a sample liquid provided for this purpose
- Aliquoting structure for example a cavity array structure
- the device can be designed such that the aliquoting structure can be connected to a microfluidic network in which an automated processing of the sample liquid, in particular a small volume of sample liquid using a
- the device can be microfluidic
- the method for operating or fundamentally using the device can in particular be carried out in such a way that, on the one hand, it enables the transport of a small volume of the sample liquid to be aliquoted in a microfluidic network using a transport liquid and on the other hand it enables the
- Aliquoting structure initially with the sample liquid and then with a sealing liquid, which can in particular be a liquid different from the transport liquid.
- the sample liquid and the sealing liquid already have a common interface during the transport to the aliquoting structure and the filling of the cavities with the sample liquid, in order to enable the cavities of the aliquoting structure filled with the sample liquid to be sealed with the sealing liquid.
- the device can also enable efficient temperature control of the sample liquid present in the cavities, spatially resolved optical detection of a fluorescence signal emanating from the sample liquid, pre-storage of reagents in the cavities of the aliquoting structure and removal of gas bubbles that form, in particular during temperature control.
- the device can be suitably aligned with a gravitational field, on the one hand, to achieve removal of gas bubbles that are forming by the buoyancy force present and, on the other hand, spatial stabilization of the two-phase interface, in particular between the sample liquid and the sealing liquid, in particular during propagation through the partitioning chamber, caused by an existing density difference.
- a microfluidic device and a method for automated or fully automated processing and aliquoting of a sample liquid can be provided, the sample liquid being transported to an aliquoting structure after processing in the device with the aid of at least one further phase that cannot be mixed with the sample liquid can, in particular lossless, with a microfluidic connection of the
- Aliquoting structure can be provided on the microfluidic network in an embodiment which is formed by capillary forces, in particular in the area of a branch, chip edge or the like, and / or by a
- Difference in density of the liquids for example when filling from below and tilting the device, and / or by a change in the fluidic resistance, in particular by a channel tapering behind the branching or by a channel tapering at the edge of the chip
- FIG. 1 shows a schematic representation of a microfluidic device according to an embodiment
- 2A shows a schematic representation of a section of a
- microfluidic device according to an embodiment
- 2B shows a schematic representation of a subsection of a
- microfluidic device according to an embodiment
- 2C is a schematic illustration of a section of a
- microfluidic device according to an embodiment
- 3 shows a schematic illustration of a microfluidic device according to an exemplary embodiment
- FIG. 4 shows a schematic illustration of a microfluidic device according to an embodiment
- 5A shows a schematic illustration of a section of a
- microfluidic device according to an embodiment
- 5B shows a schematic representation of a subsection of a
- microfluidic device according to an embodiment
- 5C is a schematic illustration of a section of a
- microfluidic device according to an embodiment
- 6 shows a schematic illustration of a microfluidic device according to an exemplary embodiment
- FIG. 7 shows a flow chart of a method for operation in accordance with an exemplary embodiment.
- a microfluidic network is in one inlet channel 111, at least one pump device 121 and at least one channel branch 114 of the inlet channel 111
- Outlet channel 112 as well as a supply channel 113 and at least two valves 131, 132 or, alternatively, a multi-way valve for controlling the
- microfluidic flow at the junction 114 is connected to a central chamber or partition chamber 115.
- the dividing chamber 115 has in particular a plurality of cavities or recesses or compartments 140, which are connected to a
- Sample liquid 10 can be filled as the first phase and can be covered with a sealing liquid 20 as the second phase, so that the sample liquid 10 remains at least partially in the cavities 140. In this way, a microfluidic aliquoting of the sample liquid 10 is achieved. Furthermore, in addition to a connection to the supply duct 113, the dividing chamber 115 also has a connection to a discharge duct 116.
- the microfluidic device 100 for processing and aliquoting the sample liquid 10 thus has the dividing chamber 115 for receiving an input volume of the sample liquid 10.
- the Distribution chamber 115 has a plurality of cavities 140 for receiving partial volumes of the sample liquid 10 that can be used for detection reactions.
- the device 100 also has a microfluidic network for fluid-mechanical opening up of the partition chamber 115.
- microfluidic network has at least one inlet channel 111
- At least one channel branch 114 into a discharge channel 112 and a supply channel 113 fluid-mechanically connected to the dividing chamber 115, at least one valve 131, 132 for influencing a fluid flow in the area of the channel branch 114 and one fluid-mechanically with the
- the device 100 has at least one pumping device 121 for conveying fluids within the device 100.
- the at least one pumping device 121 and the microfluidic network are designed to convey the sample liquid 10 as a first phase through the microfluidic network into the distribution chamber 115 in order to arrange partial volumes of the sample liquid 10 in the cavities 140, and a sealing liquid 20 as a second phase through the microfluidic network into the distribution chamber 115 in order to convey the partial volumes of the sample liquid 10 in the cavities 140 with the
- Device 100 additionally at least one thermal interface or
- the temperature control device 201 can thus in particular be used for temperature control of the first phase or sample liquid 10 enclosed in the cavities 140.
- the detection device 301 can in particular be used to optically read out a fluorescence signal, which in particular comes from the one enclosed in the cavities 140
- the device 100 is suitably oriented to a gravitational field g during processing or else set in rotation so that a
- Buoyancy force 500 results, which can be used to remove any gas bubbles 50 that may be forming.
- the pump device 121 is connected to the inlet channel 111 in a fluid-mechanical manner.
- a first valve 131 is connected between the branching point 114 and the dividing chamber 115 in the supply channel 113.
- a second valve 132 is connected into the discharge channel 112.
- 2A, 2B and 2C show schematic representations of a
- FIG. 2A shows an oblique top view
- FIG. 2B shows a top view
- FIG. 2C shows one
- the cavities 140 are located in a chip which is fixed in the partition chamber 115, for example by an adhesive connection which connects a first side of the chip and a first side of the partition chamber 115 to one another.
- the supply channel 113 leads from the first side into the distribution chamber 115.
- the discharge channel 116 is arranged on a second side of the distribution chamber 115.
- the geometry of the partition chamber 115 and the chip with the cavities 140 leads to an abrupt reduction in the spatial dimensions 1130, 1150 of the fluid-carrying area of the partition chamber 115 at the transition to the chip with the cavities 140. With this reduction in the spatial dimensions 1130, 1150 According to the Young-Laplace equation, a change in the existing capillary pressure is associated. In addition, what is known as “pinning” occurs at an edge that is present in the abrupt reduction in the fluid-carrying area. In this way, a capillary-assisted alignment of a liquid meniscus along the entire width of the chip can be promoted before the liquid wets a second side of the chip with the cavities 140.
- Capillary pressure and the fluidic resistance along the entire width of the chip also support the formation of a homogeneous flow profile in the partitioning chamber 115, in particular in the area of the cavities 140, which are arranged on the second side of the chip.
- the use of a sealing liquid with a higher density than the density of the sample liquid the introduction of the liquids on the first side of the central chamber 115 and a suitable alignment of the central chamber 115 and / or the device 100 to a gravitational field, for example by a suitable tilting of the device, a stable separation of sample liquid and sealing liquid as well as a spatially uniform propagation of the two-phase interface through the central chamber 115 can be achieved due to the existing density difference, in which each of the cavities 140 is first filled with sample liquid and then is covered with the sealing liquid.
- the device thus allows the formation of a spatially as homogeneous as possible flow profile both due to the capillary forces that occur and the force of gravity acting on the liquids.
- a reliable filling and sealing of all cavities 140 can be achieved and, on the other hand, a high transfer efficiency of the sample liquid from the microfluidic network into the cavities 140 of the aliquoting structure can be achieved; d. H. a relatively small volume of sample liquid is sufficient to fill all of the cavities 140.
- FIG. 3 shows a schematic illustration of a microfluidic device 100 according to an exemplary embodiment, in particular a schematic cross section through a device 100 according to another
- the device 100 is similar to the device from one of the figures shown above, in particular FIG. 1.
- the device 100 has two pump devices 121, 122, such as peristaltic pumps, which are suitable for generating different flow rates in the microfluidic network of Device 100 to effect.
- two pumping devices 121, 122 with different pumping volumes, both particularly rapid and particularly precise pumping of liquids can be achieved.
- Supply channel 131 to the central chamber 115 in the embodiment shown in FIG. 3 has a branch 1131 which is used to produce a spatially homogeneous flow in the central chamber 115 and serves for capillary stabilization of the microfluidic interfaces during the expansion of the flow.
- a second pump device 122 is in this case between a first
- the feed channel 113 branches into a plurality of sub-channels, here only four sub-channels as an example.
- FIG. 4 shows a schematic illustration of a device 100 according to an exemplary embodiment.
- the device 100 is similar to the device from one of the figures shown above.
- the production and control of a microfluidic flow is based on the use of an elastic membrane which can be deflected by the targeted application of pressure at defined points.
- the membrane is deflected into recesses in the microfluidic network provided for this purpose in order, for example, to displace liquids, e.g. B. in the form of a pumping chamber, or to open or close a fluidic path, e.g. B. in the form of at least one valve.
- liquids e.g. B. in the form of a pumping chamber
- fluidic path e.g. B. in the form of at least one valve.
- Inlet channel 111 three microfluidic valves are arranged, which form a peristaltic pump unit 121.
- a second pumping function 122 is implemented by combining two of the named three valves of the supply channel 111 with the pumping chamber adjoining the two valves.
- the supply channel 111 has a branch 114 into a connecting channel 113 to the central chamber 115 and a discharge channel 112.
- Connecting channel 113 has a two-stage branching 1131 in front of the
- the central chamber 115 also has a discharge channel 116.
- FIGS. 5A, 5B and 5C show schematic representations of a
- the device corresponds or is similar to
- FIG. 5A shows an oblique top view
- FIG. 5B shows a top view
- FIG. 5C shows a sectional view of the partial section of FIG
- a height 1150 of the dividing chamber 115 is significantly smaller than an extension 1130 of the supply channels 1132 of the branching 1131 at the transition to the dividing chamber 115. According to the Young-Laplace equation, this corresponds to a change in the
- Partition chamber 115 can be achieved.
- FIG. 6 shows a schematic illustration of a microfluidic device 100 according to an exemplary embodiment, in particular a schematic cross section through a device 100 according to another
- Embodiment. The device 100 here is similar to the device from FIG. 3. Differences between the device from FIG. 3 and that in FIG. 6
- the device 100 has a further chamber 117 which is connected to the microfluidic network and has a ventilation channel 118. Furthermore, the device 100 has a further temperature control device or thermal interface or heat exchange interface 202 in the area of the further chamber 117.
- the further chamber 117 can in particular be used to control the temperature of Liquids 10, 20, 30, for example for thermal degassing, can be used.
- a discharge of gas bubbles 50 which are forming can in particular be achieved through the ventilation channel 118.
- microfluidic channels 110, 111, 112, 113, 116, the pump devices 121, 122, 123 and the valves 130, 131, 132 can be used for a suitable production and control of the microfluidic flow, in particular between the dividing chamber 115, the further chamber 117 and the microfluidic network within the device 100.
- the first pump device 121 is fluid-mechanically connected between the second pump device 122 and a third pump device 123 in the inlet channel 111.
- the second pump device 122 is arranged between the first pump device 121 and the branching point 114.
- the ventilation channel 118 can be ventilated or shut off by means of a valve 130.
- the further chamber 117 is connected to the inlet channel 111 between the second pump device 122 and the branching point 114 via a further channel 110 and is connected to the inlet channel 111 between the first pump device 121 and the third pump device 123 via a channel.
- one valve is arranged between the third pump device 123 and the first pump device 121, between the third pump device 123 and the further chamber 117, between the further chamber 117 and the second pump device 122 and between the second pump device 122 and the branching point 114.
- FIG. 7 shows a flow chart of a method 700 for operation according to an exemplary embodiment.
- the method 700 for operating can be carried out in order to operate the microfluidic device from one of the figures described above or a similar microfluidic device or to control an operation thereof.
- the method 700 for operating has a step 710 of introducing the sample liquid or a sample into the device. Subsequently, in the method 700 for operating in a step 730 of bringing about a conveyance of the sample liquid as the first phase and the
- Sealing liquid as a second phase through the microfluidic network in the distribution chamber causes partial volumes of the sample liquid to be arranged in the cavities and to be sealed with the sealing liquid.
- step 730 of bringing about a conveyance has a substep 732 of manufacturing, a substep 734 of transporting and a substep 736 of reading in, as explained below.
- the sample liquid as the first phase and at least one further phase, which the
- a multiphase system is produced in the microfluidic network.
- a multiphase system can be implemented, for example, by embedding the sample liquid or first phase in a second phase which is immiscible or only slightly miscible with the sample liquid, which is both
- Sealing liquid serves as a transport liquid.
- the sample liquid and the sealing liquid can be embedded on one or both sides in a further, third phase, which serves as a transport liquid.
- the liquids used are - with the exception of constituents of the sample liquid - in particular already in front of the device before step 710 of introduction.
- the multiphase system is supplied to the at least one pump device via the inlet channel
- the at least one valve is controlled in such a way that one optionally present in the multiphase system
- Transport liquid is discharged via the discharge channel.
- a microfluidic transport of the multiphase system takes place by means of at least one pump device via the supply channel to the
- the sample liquid followed by the sealing liquid is introduced into the distribution chamber via the supply channel.
- the at least one valve is reversed after a Interface between the sample liquid and the optionally present transport liquid has passed the channel branch.
- the second valve is closed and the first valve is opened, so that the sample liquid follows, in particular after passing the channel branching through the interface between the sample liquid and the transport liquid, which is possibly identical to the sealing liquid, ie is realized by a liquid with the same physicochemical properties from the sealing liquid via the supply channel into the
- the cavities or compartments of the aliquoting structure are initially filled with the sample liquid and then covered with the sealing liquid so that the sample liquid is finally present in the cavities or compartments in aliquots.
- the method 700 also has a step 720 of entering the device into a processing unit which, among other things, serves to control the microfluidic flow within the device.
- a processing unit which, among other things, serves to control the microfluidic flow within the device.
- a pneumatic connection can be established between the device and the processing unit, which enables a controlled application of pressures to the device.
- a mechanical connection between the device and the processing unit can be established between the device and the processing unit.
- Processing unit are produced, which can transmit mechanical forces to the device, for example to release liquid reagents stored in the device, and / or the device can be set in controlled rotation so that the liquids enclosed in the device over the from the rotational movement of the device
- the processing unit can have further interfaces to the microfluidic device, which are produced in particular in step 720 of inputting, for example to at least locally temperature control the device and / or to detect an optical signal and / or to introduce ultrasound and / or to to bring in mechanical energy and / or to couple in electromagnetic energy.
- the method 700 for operating the microfluidic device, after the effecting step 730 also has a step of temperature control, in particular cyclic temperature control, of the partition chamber, which the cavities or compartments of the
- thermal interface or heat exchange interface In this way, thermally influenced chemical reactions, for example polymerase chain reactions, can be carried out in the aliquots of the sample liquid which are present in the individual cavities or compartments of the aliquoting structure.
- a detection device in particular an optical interface, additionally detects a fluorescence signal, which in particular emanates from the sample liquid in the cavities.
- a fluorescence signal which in particular emanates from the sample liquid in the cavities.
- an oligonucleotide fluorescence probe e.g. TaqMan probe
- FRET Förster resonance energy transfer
- the method 700 for operating furthermore has a step of degassing one or more of the liquids, in particular the sealing liquid, for example thermal degassing within the device in a further chamber which has a second temperature control device or thermal interface.
- the multiphase system in particular the sample liquid and the sealing liquid, is degassed and / or heated within the for this purpose provided, further chamber before the substep 134 of the transport, ie before the sample liquid and the sealing liquid are successively transferred into the dividing chamber.
- only the sealing liquid is heated and thermally degassed in the further chamber.
- the sealing liquid After the sealing liquid has been degassed in the further chamber, it is pumped into the dividing chamber, in particular after the partial step 736 of reading and before the temperature control step, so that the amount of sealing liquid present in the dividing chamber is replaced by the amount of sealing liquid previously heated in the further chamber and thermally degassed amount of sealing liquid is replaced. In this way, the amount of gas bubbles, which are particularly during the thermal
- Forming processing in the step of tempering in the partitioning chamber can be reduced.
- Lateral dimensions of the device 100 are, for example, 30 x 30 mm 2 to 300 x 300 mm 2 , preferably 50 x 50 mm 2 to 100 x 100 mm 2 .
- a thickness of polymer substrates is, for example, 0.6 mm to 30 mm, preferably 1 mm to 10 mm.
- a thickness of a polymer membrane is, for example, 50 ⁇ m to 500 ⁇ m, preferably 100 ⁇ m to 300 ⁇ m.
- Cross-sections of the microfluidic channels 111, 112, 113 are, for example, 100 ⁇ 100 ⁇ m 2 to 3 ⁇ 3 mm 2 , preferably 300 ⁇ 300 ⁇ m 2 to 1 ⁇ 1 mm 2 .
- a volume of the pump chambers of the pump devices 121, 122, 123 is for example 30 nl to 100 pl, preferably 100 nl to 30 pl.
- Dimensions of the dividing chamber 115 with the aliquoting structure are, for example, 3 x 3 x 0.1 mm 3 to 30 x 30 x 3 mm 3 , preferably 3 x 3 x 0.3 mm 3 to 10 x 10 x 1 mm 3 .
- Distribution chamber 115 with the aliquoting structure is, for example, ⁇ 1 pl to ⁇ 3 ml, preferably ⁇ 3 pl to -100 pl.
- Compartments 140 of the aliquoting structure is, for example, 10 pl to 10 pl, preferably 10 nl to 300 nl.
- Lateral dimensions of the temperature control device or thermal interface 201, 202 are, for example, 1 ⁇ 1 mm 2 to 100 ⁇ 100 mm 2 , preferably 3 ⁇ 3 mm 2 to 30 ⁇ 30 mm 2 .
- the sample liquid or first phase 10 has, for example, aqueous solutions, in particular for carrying out chemical, biochemical, medical or molecular diagnostic analyzes, in particular with sample material contained therein, in particular of human origin, e.g. B. obtained from body fluids, smears, secretions, sputum or tissue samples.
- Targets to be detected in the sample liquid are in particular of medical, clinical, therapeutic or diagnostic relevance and can, for example, bacteria, viruses, certain cells, such as e.g. B. circulating tumor cells, cell-free DNA, proteins or other biomarkers.
- the sealing liquid or second phase 20 and the transport liquid or third phase 30 in particular have mineral oils, silicone oils, fluorinated hydrocarbons such as 3M Fluorinert or Fomblin in a suitable combination, the two phases not or only slightly
- each other for example 3M Fluorinert FC-40 or FC-70 and silicone oil
- a low water solubility in order to prevent undesired mixing with the sample liquid or first phase 10
- a low viscosity in order to achieve a high Mobility, d. H. to achieve good removal of gas bubbles 50 which are forming, and / or with a low thermal conductivity in order to keep the parasitic heat losses occurring as low as possible, and / or with a low heat capacity in order to keep the thermal mass to be processed as small as possible, and / or with contained surfactants in order to reduce the interface to the sample liquid or
- the device 100 is in particular primarily made of polymers such as
- PC polycarbonate
- PP polypropylene
- PE polyethylene
- Cycloolefin copolymer (COP, COC), polymethyl methacrylate (PMMA),
- PDMS Polydimethylsiloxane
- TPE thermoplastic elastomers
- TPU polyurethane
- TPS styrene block copolymer
- constituents of materials with a high thermal conductivity such as, for example, metals such as aluminum, copper, silver or alloys or silicon, in order to improve heat exchange between those enclosed in the device 100
- microfluidic pump devices 121, 122, 123 and valves 130, 131, 132 are implemented, for example, by the pneumatically actuated deflection of a polymer membrane into recesses in at least one polymer substrate in which microfluidic channels and chambers are arranged.
- an exemplary embodiment comprises an “and / or” link between a first feature and a second feature, this should be read in such a way that the exemplary embodiment according to one embodiment has both the first feature and the second feature and, according to a further embodiment, either only the has the first feature or only the second feature.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102019209746.4A DE102019209746A1 (de) | 2019-07-03 | 2019-07-03 | Mikrofluidische Vorrichtung zum Prozessieren und Aliquotieren einer Probenflüssigkeit, Verfahren und Steuergerät zum Betreiben einer mikrofluidischen Vorrichtung und mikrofluidisches System zum Durchführen einer Analyse einer Probenflüssigkeit |
PCT/EP2020/068373 WO2021001355A1 (de) | 2019-07-03 | 2020-06-30 | Mikrofluidische vorrichtung zum prozessieren und aliquotieren einer probenflüssigkeit, verfahren und steuergerät zum betreiben einer mikrofluidischen vorrichtung und mikrofluidisches system zum durchführen einer analyse einer probenflüssigkeit |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3993905A1 true EP3993905A1 (de) | 2022-05-11 |
EP3993905B1 EP3993905B1 (de) | 2023-08-23 |
Family
ID=71465310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20736618.8A Active EP3993905B1 (de) | 2019-07-03 | 2020-06-30 | Mikrofluidische vorrichtung und verfahren zum prozessieren und aliquotieren einer probenflüssigkeit |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220305493A1 (de) |
EP (1) | EP3993905B1 (de) |
CN (1) | CN114269477B (de) |
DE (1) | DE102019209746A1 (de) |
ES (1) | ES2965145T3 (de) |
WO (1) | WO2021001355A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210121884A1 (en) * | 2012-12-21 | 2021-04-29 | Leica Biosystems Melbourne Pty Ltd | Method of producing a reagent on-board an instrument |
DE102021205954A1 (de) * | 2021-06-11 | 2022-12-15 | Robert Bosch Gesellschaft mit beschränkter Haftung | Mikrofluidische Vorrichtung, Verfahren zum Herstellen einer mikrofluidischen Vorrichtung und Verfahren zum Betreiben einer mikrofluidischen Vorrichtung |
DE102022209418A1 (de) | 2022-09-09 | 2024-03-14 | Robert Bosch Gesellschaft mit beschränkter Haftung | Mikrofluidische Vorrichtung und Verfahren zu ihrem Betrieb |
DE102022209419A1 (de) | 2022-09-09 | 2024-03-14 | Robert Bosch Gesellschaft mit beschränkter Haftung | Mikrofluidische Vorrichtung und Verfahren zu ihrem Betrieb |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8492168B2 (en) * | 2006-04-18 | 2013-07-23 | Advanced Liquid Logic Inc. | Droplet-based affinity assays |
US9180453B2 (en) * | 2008-08-15 | 2015-11-10 | University Of Washington | Method and apparatus for the discretization and manipulation of sample volumes |
JP5881936B2 (ja) * | 2009-04-20 | 2016-03-09 | ソニー株式会社 | 試料溶液導入キット及び試料溶液注入器 |
EP2891886B1 (de) * | 2012-08-31 | 2018-10-10 | The University of Tokyo | Detektor und detektionsverfahren |
CN105431726A (zh) * | 2013-06-25 | 2016-03-23 | 华盛顿大学商业中心 | 样品体积的自数字化 |
WO2017115863A1 (ja) * | 2015-12-28 | 2017-07-06 | 凸版印刷株式会社 | マイクロ流体デバイスおよび観察方法 |
-
2019
- 2019-07-03 DE DE102019209746.4A patent/DE102019209746A1/de active Pending
-
2020
- 2020-06-30 WO PCT/EP2020/068373 patent/WO2021001355A1/de unknown
- 2020-06-30 EP EP20736618.8A patent/EP3993905B1/de active Active
- 2020-06-30 ES ES20736618T patent/ES2965145T3/es active Active
- 2020-06-30 US US17/597,190 patent/US20220305493A1/en active Pending
- 2020-06-30 CN CN202080061574.3A patent/CN114269477B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
DE102019209746A1 (de) | 2021-01-07 |
CN114269477B (zh) | 2023-12-12 |
CN114269477A (zh) | 2022-04-01 |
WO2021001355A1 (de) | 2021-01-07 |
US20220305493A1 (en) | 2022-09-29 |
ES2965145T3 (es) | 2024-04-11 |
EP3993905B1 (de) | 2023-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3993905B1 (de) | Mikrofluidische vorrichtung und verfahren zum prozessieren und aliquotieren einer probenflüssigkeit | |
NL1024013C2 (nl) | Trapsgewijs (cascade) hydrodynamisch richten in microfluïde kanalen. | |
US10981166B2 (en) | Manual or electronic pipette driven well plate for nano-liter droplet storage and methods of using same | |
Saias et al. | Design, modeling and characterization of microfluidic architectures for high flow rate, small footprint microfluidic systems | |
US8043846B2 (en) | Device and method for contacting picoliter volumes of fluid | |
US20210138469A1 (en) | Microfluidic device and a method of loading fluid therein | |
EP3227023B1 (de) | Verfahren zur tropfenerzeugung | |
US20060204403A1 (en) | Micro-fluidic fluid separation device and method | |
EP3505248A1 (de) | Mikrofluidischer reaktor und system mit schneller probenbeladung | |
WO2018011085A1 (de) | Handhabung von flüssigkeiten unter verwendung eines fluidikmoduls mit bezüglich einer rotationsebene geneigter fluidikebene | |
DE60007285T2 (de) | Gerät zum kapillaren flüssigkeitstransfer in seinem inneren | |
JP2022507115A (ja) | 高い再現性を提供するマイクロ流体サンプル調製デバイス | |
KR100442680B1 (ko) | 미세 혼합 채널 장치 | |
O'Connell et al. | Sequential glycan profiling at single cell level with the microfluidic lab-in-a-trench platform: a new era in experimental cell biology | |
KR102065300B1 (ko) | 미세 주입기를 가진 미세유체분석칩 및 그 제조 방법 및 그 사용 방법 | |
JP2004157097A (ja) | 液体制御機構 | |
DE102022209346A1 (de) | Mikrofluidische Vorrichtung und Verfahren zum Betreiben einer mikrofluidischen Vorrichtung | |
DE102019202790A1 (de) | Mikrofluidische Vorrichtung zur Prozessierung von Flüssigkeiten | |
KR102065301B1 (ko) | 미세 주입기를 가진 미세유체분석칩 및 그 제조 방법 및 그 사용 방법 | |
Greiner et al. | Design analysis and 3D measurement of diffusive broadening in a Y-mixer | |
KR102013997B1 (ko) | 미세 주입기를 가진 미세유체분석칩 및 그 제조 방법 및 그 사용 방법 | |
CN210079553U (zh) | 试剂顺序加载结构、离心微流控装置及分析装置 | |
DE102016124059B4 (de) | Vorrichtung für die mikrofluidik | |
US20210197199A1 (en) | Microfluidic device channel layer | |
EP4327368A2 (de) | Fluidische transistoren und verwendungen davon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20220203 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20230322 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502020004874 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20230823 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231124 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231223 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231226 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231123 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231223 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231124 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2965145 Country of ref document: ES Kind code of ref document: T3 Effective date: 20240411 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230823 |